Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.

Bibliographic Details
Published in:Breast Cancer Research Vol. 15; no. 2; pp. 1 - 16
Main Authors: Borges, Sahra, Döppler, Heike, Perez, Edith A., Andorfe, Cathy A., Zhifu Sun, Anastasiadis, Panos Z., Aubrey Thompson, E., Geiger, Xochiquetzal J., Stor, Peter
Format: Journal Article
Published: BioMed Central 2013
Online Access:View this record in EBSCOhost